Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomised, Double Blind, Cross Over Clinical Study in Healthy Human Volunteers to Assess the Efficacy and Safety of Three Different Topical Analgesics (DCF100, TIB200 And SPR300) Versus Placebo and Active Control(s) in a Model of UV-Induced Inflammatory Pain

Next Previous
X
Search
Trial Profile

A Randomised, Double Blind, Cross Over Clinical Study in Healthy Human Volunteers to Assess the Efficacy and Safety of Three Different Topical Analgesics (DCF100, TIB200 And SPR300) Versus Placebo and Active Control(s) in a Model of UV-Induced Inflammatory Pain

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Diclofenac (Primary) ; Ibuprofen (Primary) ; Menthol/methyl salicylate (Primary) ; Diclofenac; Diclofenac diethylammonium; Ibuprofen
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Futura Medical

    • Most Recent Events

    • 14 Jul 2015 Primary endpoint has not been met. (Primary pain management (heat pain tolerance test) of SPR300), according to a Futura Medical media release.
    • 14 Jul 2015 Primary endpoint has been met. (Primary pain management (heat pain tolerance test) of TIB200), according to a Futura Medical media release.
    • 14 Jul 2015 Primary endpoint has been met. (Primary pain management (heat pain tolerance test) of TPR100), according to a Futura Medical media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top